Abstract:Background Current guidelines support primary percutaneous coronary intervention (primary PCI) as the first treatment of choice (as opposed to thrombolytic therapy) for patients with acute ST-segment elevation myocardial infarction (STEMI) especially when delivered within 12 hours of symptom onset. We aimed to evaluate the impact of different clinical pathways on reduction of reperfusion delay and subsequent improvement in outcomes in patients with STEMI.Methods From November 2005 to November 2007, 546 consecutive patients with definite STEMI, who upon arrival at the emergency room were triaged to undergo primary PCI, were included. Of them, 271 patients were brought directly to catheterization laboratory (rapid group), and 275 patients were admitted to the coronary care unit (CCU) or cardiac ward first, and then transferred to the catheterization laboratory (non-rapid group). Primary endpoint was door-to-balloon (D2B) time, and secondary endpoints included infarct size assessed by peak CK-MB level and rates of major cardiac adverse events (MACE) including death, reinfarction, or target-vessel revascularization during hospitalization and at 30-day clinical follow-up.Results Baseline clinical characteristics, angiographic features and procedural success rates were comparable between the two groups, except that more patients received glycoprotein IIb/IIIa receptor inhibitors before angiography (84.0% and 77.1, P=0.042) and had TIMI 3 flow in the culprit vessel at initial angiogram (17.1 % and 9.2%, P=0.007) in the non-rapid group. The D2B time was shortened ((108 +/- 44) minutes and (138 +/- 31) minutes, P <0.0001), and number of patients with D2B time <90 minutes was greater (22.6% and 10.9%, P <0.0001) in the rapid group. The advantages associated with rapid intra-hospital transfer were enhanced if the patients presented to the hospital at regular hours. Peak CK-MB level was significantly reduced in the rapid group. In-hospital mortality (4.1% and 5.8%) and cumulative MACE rate (7.0% and 9.8%) did not significantly differ between rapid and non-rapid groups. At 30 days, cumulative death- and MACE-free survival rates were improved in the rapid group (94.5% and 89.5%, P=0.035; 90.1% and 84.0%, P=0.034, respectively).Conclusions Clinical pathway with bypass of CCU/cardiac ward admission was associated with rapid reperfusion, smaller infarct size, and improved short-term survival for patients with STEMI undergoing primary PCI. In the future, it is essential to reduce the time delay for patients presenting at off-hours.

Effect of Time-to-reperfusion on Myocardial Reperfusion after Primary Coronary Intervention for Acute Myocardial Infarction

Association of postprocedural neutrophil count and myocardial perfusion in ST elevation myocardial infarction patients after percutaneous coronary intervention

Long-Term Prognosis of Different Reperfusion Strategies for ST-Segment Elevation Myocardial Infarction in Chinese County-Level Hospitals: Insight from China Acute Myocardial Infarction Registry

Role of ST‐Segment Resolution Alone and in Combination with TIMI Flow after Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction

Impact of Different Treatment Times on Prognosis of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

Effect of different stent implantation time for percutaneous coronary intervention on efficacy and prognosis of acute ST-segment elevation myocardial infarction

Influence of percutaneous coronary intervention timing on the prognosis of patients with acute ST segment elevation myocardial infarction

Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1

Analysis of the Clinical Effect of Reperfusion Therapies in Acute Myocardial Infarction Patients

Significance of Symptom-to-ballon Time on Patients with ST Elevation Acute Myocardial Infarction Treated with Primary PCI

Influence of the number of balloon inflations during primary percutanoeus coronary intervention on myocardial perfusion and the extent of myocardial necrosis in patients with ST-segment elevation myocardial infarction

The Short-Term Outcome of Primary Percutaneous Coronary Intervention for Patients with Acute Myocardial Infarction

Patients with ST-segment elevation of myocardial infarction miss out on early reperfusion: when to undergo delayed revascularization.

The effect of early percutaneous coronary intervention following thrombolysis on myocardial perfusion and ventricular remodeling in patients with acute myocardial infarction

Development of Myocardial Perfusion in Acute Myocardial Infarction Patients after Emergency Percutaneous Coronary Intervention

Effect of Ischemic Postconditioning on the Outcome of Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention

Effect of ischemic postconditioning in different time windows of acute myocardial infarction patients on efficiency of primary coronary intervention

Impact of Different Clinical Pathways on Outcomes of Patients with Acute St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: the Rapid-Ami Study

The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study

The Beneficial Effects of Postconditioning on No-Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with ST-elevation Acute Myocardial Infarction

Follow-up Study of the Effectiveness of Primary Percutaneous Coronary Interventional Procedure Combined with Thrombus Aspiration